NASDAQ: CLLS
Cellectis Sa Stock Forecast, Predictions & Price Target

Analyst price target for CLLS

Based on 2 analysts offering 12 month price targets for Cellectis Sa

Min Forecast
$8.00+133.92%
Avg Forecast
$8.50+148.54%
Max Forecast
$9.00+163.16%

Should I buy or sell CLLS stock?

Based on 2 analysts offering ratings for Cellectis Sa.

Strong Buy
Strong Buy
2 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CLLS stock forecasts and price targets.

CLLS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-12-23
lockedlocked$00.00+00.00%2025-10-17Find Out Why

1 of 1

CLLS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CLLS$3.42$8.50+148.54%Strong Buy
CHRS$1.64$10.00+509.76%Buy
TENX$14.27$34.50+141.77%Strong Buy
CCCC$2.56$18.50+622.66%Strong Buy
CAMP$4.69$7.00+49.25%Strong Buy

Cellectis Sa Stock Forecast FAQ

Is Cellectis Sa Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: CLLS) stock is to Strong Buy CLLS stock.

Out of 2 analysts, 2 (100%) are recommending CLLS as a Strong Buy, 0 (0%) are recommending CLLS as a Buy, 0 (0%) are recommending CLLS as a Hold, 0 (0%) are recommending CLLS as a Sell, and 0 (0%) are recommending CLLS as a Strong Sell.

If you're new to stock investing, here's how to buy Cellectis Sa stock.

What is CLLS's Price Target?

According to 2 Wall Street analysts that have issued a 1 year CLLS price target, the average CLLS price target is $8.50, with the highest CLLS stock price forecast at $9.00 and the lowest CLLS stock price forecast at $8.00.

On average, Wall Street analysts predict that Cellectis Sa's share price could reach $8.50 by Dec 23, 2026. The average Cellectis Sa stock price prediction forecasts a potential upside of 148.54% from the current CLLS share price of $3.42.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.